These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

761 related articles for article (PubMed ID: 11575039)

  • 1. Dual components of optimal asthma therapy: scientific and clinical rationale for the use of long-acting beta-agonists with inhaled corticosteroids.
    Naedele-Risha R; Dorinsky P; Craig TJ
    J Am Osteopath Assoc; 2001 Sep; 101(9):526-33. PubMed ID: 11575039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled corticosteroid therapy in asthma: a balancing act.
    Li JT
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):229-30. PubMed ID: 10094213
    [No Abstract]   [Full Text] [Related]  

  • 3. [symbol: see text] Seretide and [symbol: see text] Symbicort in asthma management.
    Drug Ther Bull; 2002 Aug; 40(8):62-4. PubMed ID: 12216339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
    Stoloff S; Poinsett-Holmes K; Dorinsky PM
    Pharmacotherapy; 2002 Feb; 22(2):212-26. PubMed ID: 11837559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of long-acting beta2-adrenergic agonists in asthma management based on updated asthma guidelines.
    Prenner BM
    Curr Opin Pulm Med; 2008 Jan; 14(1):57-63. PubMed ID: 18043276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with a long-acting beta2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma.
    Lee DK; Currie GP; Lipworth BJ
    Ann Allergy Asthma Immunol; 2005 Mar; 94(3):410-1; author reply 411-2. PubMed ID: 15801257
    [No Abstract]   [Full Text] [Related]  

  • 10. Airway subsensitivity with long-acting beta 2-agonists. Is there cause for concern?
    Lipworth BJ
    Drug Saf; 1997 May; 16(5):295-308. PubMed ID: 9187530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic interventions to reduce the risk of asthma exacerbations.
    O'Byrne PM
    Proc Am Thorac Soc; 2004; 1(2):105-8. PubMed ID: 16113421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
    Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S; Vogelmeier C; Buhl R
    Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].
    Diamant Z; Dekhuijzen PN
    Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1681-5. PubMed ID: 14513539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of combination long-acting beta-2 agonists and inhaled glucocorticosteroids for treatment of asthma.
    Kim D; Glaum M; Lockey R
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):933-40. PubMed ID: 19619072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid receptor nuclear translocation in airway cells after inhaled combination therapy.
    Usmani OS; Ito K; Maneechotesuwan K; Ito M; Johnson M; Barnes PJ; Adcock IM
    Am J Respir Crit Care Med; 2005 Sep; 172(6):704-12. PubMed ID: 15860753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchodilators: new drugs and controversies.
    Kleerup EC
    Curr Opin Pulm Med; 1997 Jan; 3(1):17-22. PubMed ID: 9139768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.